Bromide

Bromide

SCHEMBL1043056

CCCCCCCCCCCC[N+](C(C)C)(C(C)C)C(C)C.[Br-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.57
TP53 P04637 1/20 0.57
CYP3A4 P08684 1/20 0.57
ALOX15 P16050 1/20 0.57
TSHR P16473 1/20 0.57
ALOX12 P18054 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HIF1A Q16665 1/20 0.57
HSD17B10 Q99714 1/20 0.57
SLC22A1 O15245 1/20 0.52
DNM1 Q05193 9/20 0.52
HSP90AA1 P07900 1/20 0.48
RAD52 P43351 1/20 0.48
HTT P42858 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5303393 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5811390 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5303634 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5288511 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5308593 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5289382 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5289880 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5289310 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5306421 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR
SCHEMBL5295844 0.97 SLC22A1 (0.55) ALDH1A1TP53CYP3A4ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304379-B2 Silicon compound-containing solidified detergent composition and method for producing the same HIROSHIMA UNIVERSITY (JP) 2012-11-06 US claimed
US-20110172183-A1 METHOD OF FIXING ANTIBACTERIAL AGENT ARTICLE OBTAINED BY THE METHOD HIROSHIMA UNIVERSITY (JP) 2011-07-14 US claimed
CN-102105062-A Method of fixing antibacterial agent and article obtained by the method UNIV HIROSHIMA 2011-06-22 CN claimed
EP-2274985-A1 METHOD OF FIXING ANTIBACTERIAL AGENT AND ARTICLE OBTAINED BY THE METHOD Hiroshima University (JP) 2011-01-19 EP claimed
US-20100190683-A1 SOLIDIFIED DETERGENT COMPOSITIONS AND METHOD FOR PRODUCING THE SAME HIROSHIMA UNIVERSITY (JP) 2010-07-29 US claimed
EP-2186873-A1 SOLIDIFIED DETERGENT COMPOSITION AND METHOD FOR PRODUCING THE SAME Hiroshima University (JP) 2010-05-19 EP claimed
CN-107006510-B Method for immobilizing antibacterial agent and method for immobilizing antiviral agent 国立大学法人广岛大学 2023-01-03 CN disclosed
EP-2377400-B1 ANTIBACTERIAL COMPOSITION CONTAINING SILICON-CONTAINING COMPOUND, MOUTH CLEANING UNIV HIROSHIMA (JP) 2021-03-03 EP disclosed
US-9278107-B2 Antibacterial agent composition and antiviral agent composition comprising silicon-containing compound; antibacterializing method, cleaning/mouth rinsing method; method for fixing antibacterial agent and antiviral agent HIROSHIMA UNIVERSITY (JP) 2016-03-08 US disclosed
US-8859009-B2 Method of fixing antibacterial agent and article obtained by the method HIROSHIMA UNIVERSITY (JP) 2014-10-14 US disclosed
US-8304379-B2 Silicon compound-containing solidified detergent composition and method for producing the same HIROSHIMA UNIVERSITY (JP) 2012-11-06 US disclosed
CN-102333446-A Antibacterial agent composition and antiviral agent composition containing silicon-containing compound, and antibacterial method, cleaning method, gargling method, antibacterial agent and antiviral agent immobilizing method UNIV HIROSHIMA 2012-01-25 CN disclosed
US-20110293542-A1 ANTIBACTERIAL AGENT COMPOSITION AND ANTIVIRAL AGENT COMPOSITION COMPRISING SILICON-CONTAINING COMPOUND; ANTIBACTERIALIZING METHOD, CLEANING/MOUTH RINSING METHOD; METHOD FOR FIXING ANTIBACTERIAL AGENT AND ANTIVIRAL AGENT HIROSHIMA UNIVERSITY (JP) 2011-12-01 US disclosed
EP-2377400-A1 ANTIBACTERIAL COMPOSITION AND ANTIVIRAL COMPOSITION EACH CONTAINING SILICON-CONTAINING COMPOUND, ANTIBACTERIALIZING METHOD, CLEANING/MOUTH CLEANING METHOD, AND METHOD FOR IMMOBILIZING ANTIBACTERIAL AGENT OR ANTIVIRAL AGENT Hiroshima University (JP) 2011-10-19 EP disclosed
US-20110172183-A1 METHOD OF FIXING ANTIBACTERIAL AGENT ARTICLE OBTAINED BY THE METHOD HIROSHIMA UNIVERSITY (JP) 2011-07-14 US disclosed
CN-102105062-A Method of fixing antibacterial agent and article obtained by the method UNIV HIROSHIMA 2011-06-22 CN disclosed
EP-2274985-A1 METHOD OF FIXING ANTIBACTERIAL AGENT AND ARTICLE OBTAINED BY THE METHOD Hiroshima University (JP) 2011-01-19 EP disclosed
US-20100190683-A1 SOLIDIFIED DETERGENT COMPOSITIONS AND METHOD FOR PRODUCING THE SAME HIROSHIMA UNIVERSITY (JP) 2010-07-29 US disclosed
EP-2186873-A1 SOLIDIFIED DETERGENT COMPOSITION AND METHOD FOR PRODUCING THE SAME Hiroshima University (JP) 2010-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172183-A1 METHOD OF FIXING ANTIBACTERIAL AGENT ARTICLE OBTAINED BY THE METHOD FBL, AOC1, CDC20 ALDH1A1 3476/4885TP53 3952/4885CYP3A4 2915/4885
US-20110293542-A1 ANTIBACTERIAL AGENT COMPOSITION AND ANTIVIRAL AGENT COMPOSITION COMPRISING SILICON-CONTAINING COMPOUND; ANTIBACTERIALIZING METHOD, CLEANING/MOUTH RINSING METHOD; METHOD FOR FIXING ANTIBACTERIAL AGENT AND ANTIVIRAL AGENT SEM1, LSM14A, SSRP1 ALDH1A1 2204/4885TP53 3238/4885CYP3A4 2867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.